David Mott - Profile and Investment Details

Investor Profile

David Mott is a Venture Capital, Angel/Individual, Investor based in Big Sky, Montana, United States with a diverse investment portfolio that includes companies such as Nightstar Therapeutics, NightstaRx Limited, Ardelyx, Cydan, Adaptimmune, Omthera Pharmaceuticals, Polyneuron Pharmaceuticals AG, St. Albans School (D.C.)Prosensa, XTuit Pharmaceuticals, Inc., Yellowstone Club Community Foundation, Ambit Pharmaceuticals, Beauvoir Elementary School, Big Sky Youth Empowerment, Clementia Pharmaceuticals, Edimer Pharmaceuticals, Shire, RibX Pharmaceuticals, Omthera Pharmaceuticals, Inc., Saint James School, Tiburio Therapeutics, . Over time, David Mott has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether David Mott is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Enterprise Software, Biotechnology, Health and Hospital Services, Consumer Internet, Water Management, Pharmaceuticals may find it worthwhile to explore potential connections with David Mott, as their portfolio suggests a familiarity and interest in this area.

Understanding David Mott’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.